🇧🇷 Alhemo in Brazil

Alhemo (CONCIZUMAB) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Alhemo in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Rare Disease approved in Brazil

Frequently asked questions

Is Alhemo approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Alhemo in Brazil?

Novo Nordisk Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.